P&L Archives

Subscribe to the P&L RSS feed.

For Executives with P&L responsibility

CEO Search for DCIM/Cloud Software Pioneer

Our client is a leading innovator of data center infrastructure  management software for large enterprises, government agencies, and managed service providers. Their  solutions provide visibility, intelligence, analytics and automation to help CIOs manage and optimize up-time within and across data centers.

The Position

Highlights of the new CEO’s track record and experience will include the following:

• Strong commercialization stage leadership experience, with a focus on establishment of both direct and channel sales distribution and post-sales service support

• Experience with oversight of manufacturing “whole solution” electromechanical systems

• Executive team-building, with particular emphasis on the sales, marketing & business development side

• Corporate Development expertise in developing key strategic partnerships across the targeted Harvest customer ecosystem

• Success taking new products “cross-chasm” into new markets

• Experience taking companies from pre-revenue to $50M+

• Experience with global expansion, customer identification and development

• Equity capital-raising

Ideal Candidate Profile

The following diagram illustrates the intersection of competencies critical in the Chief Executive Officer position:

BSG Team Ventures completes Bay Area Medical Devices CEO search for Novel Suturing Technology out of Stanford University

BSG  Team Ventures is pleased to announce the successful completion of CEO search for Zipline Medical.

BSG recruited John Tighe, former CEO of PEAK Surgical, to join Zipline Founder & Chief Technology Officer Dr. Amir Belson.

Prior to being recruited to ZipLine Medical, Mr. Tighe was a Director and President and CEO of PEAK Surgical, joining the company as its first employee in June 2006. In July 2011, he negotiated the acquisition of PEAK Surgical by Medtronic. Mr. Tighe was responsible for establishing clinical development and sales of PEAK’s novel radio frequency technology in a variety of surgical specialties, including General Surgery, ENT, Orthopedics, and Plastic Surgery. Prior to joining PEAK, he served as Senior Vice President and General Manager at Arthrocare Corp., where he managed the company’s three business units, comprised of Sports Medicine, ENT, and Spine. During his time at the company, Arthrocare was one of the fastest-growing publicly traded medical device companies. Mr. Tighe is a member of the Community Advisory Board of El Camino Hospital of Los Gatos (CA), and earned a bachelor’s degree in Civil Engineering at the University of Maryland.

ZipLine Medical (www.ziplinemedical.com), headquartered in Campbell, Calif., is an emerging medical device company that has developed a platform technology — PRELOCTM (Pre-placement RE- aligning Low-tension Closure) — for noninvasive surgical skin closure via a simple, easy-to-learn and easy-to-use device. Because skin-closure is a common denominator of almost all surgeries, ZipLine’s PRELOC platform for the pre-placement, reapproximation and low-tension realignment of skin tissue has broad applicability across numerous medical specialties. There is an existing $4.2 billion worldwide market opportunity covering most surgical procedures involving skin incision. ZipLine’s initial target applications include: C-section, laparotomy, pacemaker/ICD implant, laparoscopic port, orthopedic, and excisional skin biopsy closure.

For more information see, Zipline press release at

http://www.ziplinemedical.com/press_release/zipline-medical-announces-appointment-of-john-r-tighe-as-ceo/

CEO Search | Robots that automate $8B+ problem

BSG Team Ventures is excited to be engaged on the CEO search for an emerging, venture- backed robotics company that develops and sells automation systems into an $8B+ market where tasks are currently executed entirely via manual labor.   The first product is in beta and moving toward commercial launch September of this year.

The current co-founder & CEO has successfully taken the company from concept through design & beta launch.  He’s driving the search for his replacement as they enter their next stage of growth to maximize the company potential they’ve built up over the last 3+ years of research, development and customer learning.  He’ll step into the co-pilot role with the new CEO driving commercial adoption, sales expansion, and next generation product roadmap.

The company is looking for a strong sales, marketing & strategy savvy builder-leader to step in and take over the pilot role.

________

COMPANY HIGHLIGHTS


  • ONE OF MOST EXCITING NEW INNOVATION FRONTIERS Robotics/automation
  • DEEP ENGINEERING BENCH with  founding team members responsible for the initial success and IPO of iRobot
  • LARGE ADDRESSABLE TARGET MARKET–$2.5B for first product, $8B+ market for planned 2nd generation products, automating an otherwise manual-labor intensive industry with a first to market solution
  • READYING FOR COMMERCIAL LAUNCH NOW with growing backlog for commercial units driven from successful field beta trials over the last 6+ months
  • WELL-FUNDED with 9-12 months of runway

________

THE CEO NEED

As CEO, we’re looking for the following 4 prior experiences as a builder-leader:

• Success in companies that integrate hardware, software, and electromechanics

• P&L leadership of  a direct sales-driven and field services intensive organization selling into a large global customer base

• Strong grow-it/scale-it-stage experience, having grown companies or divisions from new product launch to $25M or more in revenues

• Prior track record of recruiting and motivating A-caliber teams

Companies that might be part of this executive’s career progress cover a broad spectrum of industries sectors, including industrial automation, light vehicle developers, medical devices, aerospace & military technologies, or mission critical hardware/software systems.

The following bubble diagram frames the key success attributes critical to the role—

For more information, contact Clark Waterfall, Managing Director.

2nd Annual Cooley Medical Device Growth Conference – Boston, November 9, 2011

We’re pleased to partner with Cooley LLP, Ernst & Young & BMO Capital Markets to put on this invitation-only conference.  Below is an agenda overview and speaker highlights.

If interested, please email clark [at] bsgtv.com.

WEDNESDAY, NOVEMBER 9, 2011 |  12:00 noon – 7:00 pm

Mandarin Oriental, Boston 776 Boylston Street  |  Boston, Massachusetts

Cooley LLP, Ernst & Young LLP and BMO Capital Markets invite you to an exclusive gathering of leading executives, investors, entrepreneurs and thought leaders in the medical device industry for the second annual Cooley Medical Device Growth Conference in Boston. This event will focus on the key drivers affecting the medical device industry and explore growth strategies for medical device companies.

KEYNOTE SPEAKER

Dr. Michael J. CimaProfessor of Materials Science and Engineering, Massachusetts Institute of Technology

TOPICS TO BE DISCUSSED [ view full agenda ]

  • Pulse of the Industry: Medical Technology Report 2011 – Ernst & Young’s annual report on the medical device industry
  • Developing and Implementing a Sales & Marketing Strategy -  Keys to achieving growth and ensuring regulatory compliance
  • An Open Discussion with Thought Leaders – A fireside chat with CEOs at revenue stage medical device companies on the medtech industry, opportunities and challenges, lessons-learned, etc.
  • What’s Getting Done? A discussion of trends in IPOs, M&A deals and strategic collaborations

REGISTRATION REQUIRED. This event is by invitation only. Registration is limited to representatives of medical device companies and investors, and is subject to approval.

PANELISTS AND MODERATORS INCLUDE

  • Joseph ArmyGeneral Manager, Medtronic Advanced Energy (Formerly President and Chief Executive Officer, Salient Surgical Technologies)
  • Michael CimaProfessor of Materials Science and Engineering, Massachusetts Institute of Technology
  • Kevin CaseyPartner, Ernst & Young LLP
  • Drew GanttPartner, Cooley LLP
  • Ron GoldmanChief Executive Officer, Accuvein
  • Larry KnopfSenior Vice President and General Counsel, HeartWare, Inc.
  • Michael McGrailAttorney, Cooley LLP
  • Yiannis MonovoukasChairman, President and Chief Executive Officer, TEI Biosciences Inc.
  • Michael NeubergerManaging Director and Head of Healthcare Group, BMO Capital Markets
  • Stu RandlePresident and Chief Executive Officer, GI Dynamics
  • Charles SherwoodPresident and Chief Executive Officer, Anika Therapeutics, Inc.
  • Mark SpeersPartner and Managing Director, Health Advances
  • Peter StebbinsVice President, New Business Development, DePuy Mitek and Codman, J&J Family of Companies
  • Kevin SeifertChief Executive Officer, Facet Technologies, Inc.
  • Don SternPartner, Cooley LLP (Former US Attorney)
  • Mark WeeksPartner, Cooley LLP
  • Robert WhitePresident & Chief Executive Officer, TyRx, Inc.

Chief Operating Officer Search for Growing Sound Masking Technology Provider

The Company

Creating Privacy in the Workplace via Technology

Our client is a pioneer in sound masking, paging and music engineered systems. Their products  feature cutting-edge distributed audio technology for the workplace that combines extraordinary audio performance, low impact installation and affordability. Their systems are deployed in millions of square feet of workspace while supporting normal acoustical privacy in open plan spaces and confidential speech privacy in private offices.

The company is headquartered  in the Northeast United States.

The Position

As heir apparent and key member of the management team, the Chief Operating Officer will partner with the CEO on strategy, sales & marketing as well as all decision-making issues affecting the organization Key to the role is an ability to bring prior experience and success in building and growing multiple distribution channels, scaling teams and organizations from 25 to 50+, and expanding domestic and international partners and customers.

Ideal Candidate Profile

The diagram below illustrates a comprehensive intersection of competencies critical in the COO position:

The COO’s core responsibilities will include the following—

Strategy, & Product Marketing Direction:

Collaborating with the CEO to establish a short and long-term business direction that drives the company to become an industry leader and maximize the penetration of the markets served. The COO will bear primary responsibility for refining and carrying out The Company’s strategy. This will include such activities as monitoring The Company’s current markets and its standing within them; assessing current and potential competitive activity; and evaluating opportunities for growth (new but related products, entirely new initiatives which leverage the Company’s relationships, intellectual property and intellectual capital, possible acquisitions, etc.).

Marketing:

Ensuring close symbiotic relationship between product development and customer market needs, creating demonstrable competitive differentiation and performance benefits of CSM products vis-à-vis industry competitors.

Sales & Business Development Leadership:

Setting the approach to commercialization, including direct sales, distributor agreements, and independent representative networks. First and foremost, the COO will play a hands-on role in building The Company by acting as its most-senior business generator and evangelist. He or she must understand both The Company’s capabilities and the market’s needs, and combine those understandings to identify and pursue specific new opportunities.

Engineering, Manufacturing & Operations:

To a lesser extent the COO will share oversight of engineering, manufacturing and production teams responsible for product development, production, establishing build/buy/outsource decisions, quality control etc.

Staff— team building, development, mentorship:

The COO is responsible for human capital planning and hiring. As important, the position will actively be responsible for developing new and existing staff to help prepare them for company growth and increased leadership responsibilities at all levels. Finally, the new COO will serve as leader and mentor to the founding team and as a complement to their existing skills. He or she will do this through personal interactions with colleagues, as well as by maintaining management practices which reinforce a positive internal culture and help the company establish a reputation as a rewarding place to build a career. This individual will be expected to set high standards and hold people accountable, and to create an environment in which people work cooperatively and focus on building the long-term value of the enterprise. When management slots open up, the COO must be able to hire executives who can make significant contributions, not only as individuals but by building effective teams in their own areas of the business; he or she will also have to upgrade the organization when necessary by replacing underperformers with strong new recruits.

Investors/shareholders & board — milestone management, any follow-on fundraising, and liquidity strategy: Along with the CEO, the new COO is co-liaison to the board and will aggressively manage milestone deliverables, be a key leader at board meetings and to board/investor communications. The COO will be responsible for developing and managing against an annual operating plan and in addition to possible follow-on fundraising, will be accountable for optimizing the harvest for all shareholders. This includes continuous improvement of operational efficiency and effectiveness by assessing, upgrading or installing new operational systems, processes and methodologies. In addition, the COO will continually review activity reports and financial statements to determine progress and status in attaining objectives and revise tactics in accordance with current conditions. Combining these, the COO will execute and achieve annual growth targets while gaining increased leverage on costs and operating expenses.

STAGE:

Key background & successful experience with company growth stage includes—

• Board/investor communication and management

• VP level hiring across the organizational spectrum

• Growing sales from `$5M to >$50M

• Industry partner mapping for growth and harvest

• M&A negotiation experience

INTERNATIONAL:

Previous exposure to international business, in particular international dealer and distribution channels is beneficial. This includes the ability to work effectively in other parts of the world, and an appreciation for the ways in which cultures and business practices differ from country to country.

EDUCATION:

Undergraduate degree required, with preference for mechanical or electrical engineering, MBA or other advanced degree a plus.

GENERAL:

Finally, this individual should have as many as possible of the traits required to succeed in any CEO position:

• High levels of intelligence, analytical strength and conceptual ability.

• The ability, and willingness, to set and communicate demanding standards for professional staff and to hold people accountable for their performance; at the same time, sensitivity to, and insight into, individuals’ capabilities and development needs.

• Decisiveness when necessary, coupled with a willingness to seek input and build consensus as much as possible.

• Unquestioned honesty and integrity; also, loyalty to colleagues and to the organization, and the ability to inspire loyalty. This person should have the ability to identify and focus on The Company’s best interests, rather than the agenda of any individual or group within the Firm.

• A very high level of energy and commitment, combined with enthusiasm and a positive attitude.

• Excellent writing and speaking skills; this individual must be able to communicate complex ideas and information clearly and concisely.

• Outstanding planning and organization skills.

• Good strategic instincts and long-term vision; the ability to address both big-picture issues and detailed, day-to-day management concerns.

• In general, the business and personal skills, and the absolute commitment, required to make a major contribution to The Company during the coming years.

Team

Reporting to the CEO, the COO shares the responsibility for sales, marketing, operations, product and finance. Total employee base is approximately 25 and growing.

Financial Backing & Budget

The Company is profitable and growing at a 30%+ annual rate.  Seed and growth capital has been provided by one strategic partner in a joint-venture structure.  No other outside investment capital has been required.

Compensation

Compensation is competitive with the position’s requirements. In a performance-based environment, this will include base salary, incentive bonus structure based on both individual and company milestones, and a stakeholder position in the company.

CEO search, break-through medical devices for wound closure

BSG Team Ventures has been retained to bring aboard the new CEO for a break-through approach to wound closure.  The company has a patent portfolio and 4 products, two already with FDA approval, and a new Series B round of funding from passionate venture capital partners.

The addressable market is more than $5 Billion, and includes applications for plastic and reconstructive surgery, biopsy, military, perinatal, laproscopic, and other orthopedic surgical procedures.

The company is currently located in the San Francisco Bay area, California, having been founded in 2007.

Highlights of the new CEO’s track record and experience will include the following:

  • Strong commercialization stage leadership experience, with a focus on establishment of both direct and channel sales distribution
  • Experience with oversight of manufacturing and clinical trials for 510K regulatory approvals
  • Executive team-building, with particular emphasis on the sales, marketing, business development, manufacturing, and operations side
  • Corporate Development expertise in developing key strategic partnerships across the medical consumables/disposables ecosystem
  • Experience taking companies from pre-revenue to $50+M in revenues
  • For a more detailed outline of key success attributes, see the Venn diagram below.

    For more information regarding this search, please email clark [at] bsgtv-dot-com.

    CEOs & VCs gather to talk about “new normals” as they face 2011

     

    “]
    Rob Day, Black Coral Capital | Michael Balmuth, Edison Ventures | Alexis Borisy, Third Rock Ventures

    Once or twice a year we as a firm gather CEOs from the Boston innovation ecosystem to share thoughts amongst themselves.  Often, the format is lubricated by a panel to kick things off.  Always, the format is lubricated by an open bar and dinner.

     This Fall’s CEO gathering in early November brought together 50 or so CEOs around the topic of planning for 2011, and what to expect as a CEO. 

    Whether early-stage venture, or mid-stage growth, investors are adopting a different approach to what they are looking for, how much they are putting to work, and what they expect to see as an end result.  This is proving true not just in the tech sector, but cleantech, medical device, and biotech.

     If CEOs are looking for more investment, whether growth equity, seed capital, or something in between, what are the “new normals” to think about going into 2011.  And if CEOs aren’t looking for money, but looking for exits, what are the expectations of investors in 2011 and beyond? 

     We assembled a panel of venture capital investors who all had raised new funds in the last year or so.  These investors also represented a different flavor than traditional venture capital.

     On the panel? 

    • Michael Balmuth, General Partner, Edison Venture Fund
    • Alexis Borisy, Partner, Third Rock Ventures
    • Rob Day, Partner, Black Coral Capital

     What were the “new normals” CEOs and VCs talked about?

     Here are a few that got some air time:

    2011 is likely to be an economic “ground hog year.”  The current economic cycle of “flat is the new up” is here to stay for the medium term;  In taking a flash vote of the room, the overwhelming majority felt that the economic conditions in which companies are being created are not going to change for the better any time soon.  Simply turning the calendar over from 2010 to 2011 is not likely to yield a more fertile or forgiving economic climate in which to grow innovation-stage companies.  In our recent survey  of growth-stage CEOsfor Q4 2010, we noted in a prior blog post that the vast majority of CEOs had already shifted their strategies or were planning to in the near future as a direct result of an expectation that 2011 might look a lot more like the end of 2009 or 2010 than ’07 [see CEO survey pie chart below]

     

    Seed rounds are becoming pervasive compared to prior quarters.  And these aren’t for Web 2.0 companies only.  CB Insights in their Q3 2010 summary demonstrated that this is a trend that is occurring in cleantech / greentech as well as healthcare IT.  All 3 investors on the panel agreed that seed funding makes sense.  Alexis Borisy, Partner at Third Rock Ventures, talked about their approach to seeding, saying that they tend to help start the companies, not just fund them, often taking an interim role on the executive team to incubate to a point of value inflection.  Michael Balmuth mentioned that although Edison Ventures doesn’t do “seed stage investing” per se, he loves to see companies that get seed rounds, as it often is an effort to drive toward profitability faster.  At that point, Edison may be more interested in a seed-funded company that achieves an early positive cash flow position than a typical heavily syndicated, multi-series venture-backed portfolio company.  Black Coral’s Rob Day added that he felt that investing in capital-efficient companies, even in the cleantech sector, was something he has advocated for a long time.  [see CB Insights graph of growth in seed round funding over last 5 trailing quarters, 2009-2010]

    • As an asset class, venture funds have lost money for a while now.  Limited partner investors in venture capital and even private equity believe that they still have to invest in this asset class because it does make money during economic or industry sector bubble periods, and to invest once a bubble has been established would mean missing the upside.  During other times, LPs try their best to pick the funds that outperform their peers.

     

    • Using investment banks to raise equity capital  should be done selectively.  If the industry is a small one, and the network is well established (like biotech investing Alexis pointed out), using an i-bank at an early stage is not the best idea.  However, in the cleantech sector where there are more total number of investors, they are internationally distributed, the industry is younger and less well-networked, and there is an imbalance in demand-supply (more money chasing fewer good deals), the investment banking solution may be just the right one.  One CEO, Larry Letteney of Second Wind in the cleantech sector, shared just such a recent positive experience in going out for their next round. 

     

    • Seek out funds that have real capital to invest, preferably “fresh.”  Each of the three funds represented on the panel had all raised funds in the last twelve months or so.  But there are a lot of funds that are at the end of their last fund.  Many are unlikely to raise another fund.  Many investors are taking meetings, but setting the bar exceedingly high because they have only an investment or two left, and they don’t want to get caught making a bad one given the challenge in delivering returns to LPs in the most recent investing vintages.  There was also a “beware” comment about funds who are making seed round investments at the end of their funds.  They are more likely to do so, as it is an easier story to message an investment mulligan to LPs if you can just say, “It was just a small seed investment, so no biggie.”  Caution was also expressed that an investor at the end of a fund making a seed investment will be less likely to have additional capital to invest even if the company is doing well.

    We hope to post a video snippet of the the VC-CEO dialogue for a flavor of the evening’s conversation in the near future.

    How long do executive searches take? How many get completed? How many candidates interviewed?

    Survey of 50 of the Fortune 500 companies reveals how long executive searches take, the average number of candidates interviewed,  how many of them actually get completed, and what percentage of those candidates are female or minority.

    As executive search consultants, we often get asked a series of questions by our client companies surrounding the executive search process.  Many of these questions are driven at gathering market intelligence around our executive recruiting.   The aim?  To create some third-party benchmarks to help companies understand whether a search has gone about average, better than average, or (gulp) “below the mean.”  Keep in mind, these could be internally run searches done in the “DIY” fashion.  Or searches executed by in-house recruiting departments or human resources staff.

    Historically, there has been precious little data generated by third-party sources with enough statistical heft to garner much credibility.

    One of the sources that at least aims to collect good data is created by David Lord, who heads the Executive Search Information Services organization.  David is a veteran observer and analyst of the executive recruiting industry, and has run a roundtable of senior talent executives from Fortune 500 companies for the last 20 years or so.  For further information, see www.davidlord.com.  Some of the data that ESIS collects is via an annual survey of those senior human resources executives who participate in these roundtables.

    For our clients, we often reference ESIS data when made available.  At our request, below is a data table we created from some of the information ESIS kindly provided that shows some longitudinal data over the last 4  years, 2006, 2008, and 2009.

    Trends worthy of note?

    Search completion times have come down by almost a month from near 5 months down to 3.5 months.  Good news for all, the company, the candidates, and the search firm.   It will be interesting to see if this flattens out, or jumps back up for 2010 due to tightening talent pool on the supply side as the economy began to pick back up this year.

    Number of candidates interviewed per hire dropped from 6.5 to ~5.  This could be an indication of a company’s increasing confidence in what they’re looking for, or an indication of sense of urgency around key hiring to help companies as they struggled through a very tough 2009.

    Female and minority hiring at the executive level has improved, but not as much as many would have thought. Women executives were hired 29% of the time in 2009 versus 23% in 2006.  Compared to the workforce percentages of women to men, this is still inversely proportioned.  Minorities have seen a nominal increase of 1% more hired over  the last 5 years, which–when considering rounding errors– is effectively no increase at all.

    Search completion rates have remained flat, with 4 out 5 searches engaged getting completed. Over the last 5 years,  search completion rates have hovered around 80%.  This is reported by corporations only, so subject to different numbers search firms might proffer.

    Retained executive search statistics, 2006-2009

    For deeper data, please contact ESIS.

    Additional footnotes worthy of note:

    1) For some reason, executive search firms specializing in the financial services sectors and related areas often calculate their “days to complete” numbers counting only business days, excluding weekends and bank holidays.  This can often make comparing normative data a bit more troublesome

    2) Days to completion numbers are calculated using the date of accepted offer of employment, not candidate start date/first day of work.  This is done because resignation periods vary widely and would undermine data integrity.

    team

    CEO Survey, Fall 2010

    TOPIC: How & What Growth-stage CEOs Are Planning for 2011

    Below is the hyperlink to take the Q4 CEO peers speed-survey, exclusively for growth-stage CEOs.  This survey focuses on “How & What Growth-stage CEOs are Planning for 2011″

    This shouldn’t take more than 5 minutes of a busy CEO’s time–

    We here at BSG Team Ventures periodically take the temperature of the markets we serve. The survey is no more than 15 questions, most simple multiple-choice.

    These surveys are created and compiled by BSG Team Ventures as a courtesy to our executive ecosystem with the belief that knowledge is power.  Aggregated peer-provided knowledge is “actionable power.”

    For the survey results from Q2 2010, titled “Impact of Economy & Renewed Growth Planning”, go to http://www.bostonsearchgroup.com/blog/ceo-survey-results-q2-2010-%E2%80%93-impact-of-economy-renewed-growth/

    We make an effort to survey only those who fit the category (in this case, sitting CEOs or board member/founders of technology/science-driven growth-stage companies). [Note, if you don't fit the aforementioned description, please refrain from responding.]

    Feel free to forward to the qualified CEOs in your sphere of influence. The more data generated, the more accurate the trend lines.

    All responses are anonymous due to the web-based survey technology employed.

    We will forward the survey results within the next two weeks to the email address on file. Please let us know if there is another email address you wish us to send the results to as well.

    Announcing Registration Open – VCs vs. Entrepreneurs Charity Tennis Tournament


    img_3658img_3650img_3600

    Registration is Now Open

    4th Annual Benefit

    VCs vs. Entrepreneurs – Davis Cup Challenge

    Thursday, September 23, 2010
    Longwood Grass Courts  /  2:00 – 7:30pm

    Welcome Back!  BSG Team Ventures is proud to once again host the 4th Annual  Benefit: VC vs.  Entrepreneur Tennis Tournament – Davis Cup Challenge, and we are thrilled to have you join us.

    The VC/Entrepreneur tennis community has been growing every year so please register now so we can build the teams early.

    Entry is by donation of $175.00.  Please click here to register!

    For questions, please email Cristina Vieira Abramson at cvieira@bsgtv.com or call 617.784.4987

    Agenda Overview

    VCs vs. Entrepreneurs - Thursday, September 23, 2010

    Format - Round Robin, Doubles

    Time - 2:00 – 7:30pm (includes tournament, finals, cocktails, dinner and networking)

    Location – Longwood Cricket Club, Chestnut Hill, MA

    REGISTER


    The Benefiting Charity and Partner
    TENACITYTransforming Youth and Building Community. Founded in 1999, Tenacity has served over 20,000 Boston students who otherwise would lack a safe, productive, and healthy after-school and summer environment.  Our high-quality literacy and tennis programming not only build academic skills and improve fitness, they also foster the development of strong bonds between our students and caring staff, which instills the resilience needed to succeed in school and life.


    « Older Posts